Glenmark Pharmaceuticals Limited has informed the Exchange that the Board approves Dividend and as intimated earlier Record date for the purpose of Dividend is 03-Oct-2025.
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals' Board has approved an Interim Dividend of ₹2.50 per equity share (on face value of ₹1) for FY 2025-26, totaling around ₹705.50 million. The record date for eligibility is October 3, 2025, and the dividend will be paid within 30 days of declaration. Separately, the Board reconstituted three committees — Stakeholders Relationship, Risk Management, and ESG — effective October 1, 2025, with new chairpersons and members appointed.
Shareholders on record as of October 3, 2025, will receive the ₹2.50 per share interim dividend. The ₹705.50 million payout is modest in scale and is unlikely to materially move the stock price on its own, though it signals continued shareholder returns by the company.